The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2024 | Promising era: non-invasive tests for colon cancer screening
Aasma Shaukat, MD, MPH, New York University, New York, NY, discusses the promising nature of non-invasive tests for colorectal cancer screening. She highlights that the widespread adoption of these tests will depend on the results of studies, particularly in terms of sensitivity for detecting colon cancers and precursor lesions like adenomas. Factors such as availability, convenience, and cost will also play a crucial role in determining adoption. Dr Shaukat notes the high interest, particularly among younger individuals, in non-invasive screening options for colon cancer. This interview took place at the 2024 ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
